Skip to main content

4 Result(s)

within Yuiko Miyase Remove this filter

and

  1. No Access

    Article

    Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease

    We hypothesized that cholesterol efflux capacity is more useful than the lipid profile as a marker of the presence and the severity of coronary artery disease (CAD). Therefore, we investigated the associations...

    Kenji Norimatsu, Takashi Kuwano, Shin-ichiro Miura, Tomohiko Shimizu… in Heart and Vessels (2017)

  2. No Access

    Article

    Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography

    Smoking promotes arteriosclerosis and is one of the most important coronary risk factors. However, few studies have investigated the association between smoking habits and the severity of coronary stenosis as ...

    Masaya Yano, Shin-ichiro Miura, Yuhei Shiga, Yuiko Miyase… in Heart and Vessels (2016)

  3. No Access

    Article

    Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?

    The objective of this study is to determine whether pentraxin-3 (PTX-3) is clinically a biomarker of inflammation, a player in anti-inflammation, or both with regard to coronary atherosclerosis, we compared le...

    Ayumi Nakamura, Shin-ichiro Miura, Yuhei Shiga, Kenji Norimatsu… in Heart and Vessels (2015)

  4. No Access

    Article

    Contrast between innovator drug- and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study)

    Contrast-induced nephropathy (CIN) has gained increasing attention in clinical practice, particularly during coronary angiography (CAG). However, some “bioequivalent” generic (GE) drugs are less effective than...

    Ayumi Nakamura, Shin-ichiro Miura, Makoto Sugihara, Yuiko Miyase… in Heart and Vessels (2014)